Genome-wide association study identifies genetic determinants of warfarin responsiveness for Japanese
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Genome-wide association study identifies genetic determinants of warfarin responsiveness for Japanese
Authors
Keywords
-
Journal
HUMAN MOLECULAR GENETICS
Volume 19, Issue 23, Pages 4735-4744
Publisher
Oxford University Press (OUP)
Online
2010-09-11
DOI
10.1093/hmg/ddq389
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genetic and Clinical Predictors of Warfarin Dose Requirements in African Americans
- (2010) L H Cavallari et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pharmacogenetic relevance of CYP4F2 V433M polymorphism on acenocoumarol therapy
- (2009) V. Perez-Andreu et al. BLOOD
- Genetic Factors (VKORC1, CYP2C9, EPHX1, and CYP4F2) Are Predictor Variables for Warfarin Response in Very Elderly, Frail Inpatients
- (2009) E Pautas et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- A genome-wide association study of acenocoumarol maintenance dosage
- (2009) Martina Teichert et al. HUMAN MOLECULAR GENETICS
- CYP4F2 Is a Vitamin K1 Oxidase: An Explanation for Altered Warfarin Dose in Carriers of the V433M Variant
- (2009) M. G. McDonald et al. MOLECULAR PHARMACOLOGY
- Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data
- (2009) NEW ENGLAND JOURNAL OF MEDICINE
- CYP4F2 genetic variant (rs2108622) significantly contributes to warfarin dosing variability in the Italian population
- (2009) Paola Borgiani et al. PHARMACOGENOMICS
- Genetic determinants of warfarin dosing in the Han-Chinese population
- (2009) MT Michael Lee et al. PHARMACOGENOMICS
- A Genome-Wide Association Study Confirms VKORC1, CYP2C9, and CYP4F2 as Principal Genetic Determinants of Warfarin Dose
- (2009) Fumihiko Takeuchi et al. PLoS Genetics
- CYP4F2 genetic variant alters required warfarin dose
- (2008) M. D. Caldwell et al. BLOOD
- The largest prospective warfarin-treated cohort supports genetic forecasting
- (2008) M. Wadelius et al. BLOOD
- A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose
- (2008) G. M. Cooper et al. BLOOD
- Ethnic Differences in Cardiovascular Drug Response
- (2008) Julie A. Johnson CIRCULATION
- Pharmacogenetics of Warfarin: Development of a Dosing Algorithm for Brazilian Patients
- (2008) JA Perini et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The Critical Path of Warfarin Dosing: Finding an Optimal Dosing Strategy Using Pharmacogenetics
- (2008) LJ Lesko CLINICAL PHARMACOLOGY & THERAPEUTICS
- Dosing Algorithms to Predict Warfarin Maintenance Dose in Caucasians and African Americans
- (2008) H Schelleman et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- WGAViewer: Software for genomic annotation of whole genome association studies
- (2008) D. Ge et al. GENOME RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search